Fredrik Ollila
Gründer bei BonAlive Biomaterials Oy
Profil
Fredrik Viktor Ollila is the founder and currently holds the position of Director at BonAlive Biomaterials Oy, a company founded in 2009.
In the past, Dr. Ollila worked as Director-Sales & Marketing at Vivoxid Oy from 2006 to 2014.
Dr. Ollila also held positions at Novartis AG and Novartis Pharma AG as a Principal.
Dr. Ollila's education includes an undergraduate degree from the University of Turku and a doctorate degree from Åbo Akademi University.
Aktive Positionen von Fredrik Ollila
| Unternehmen | Position | Beginn |
|---|---|---|
BonAlive Biomaterials Oy
 BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland. | Gründer | 13.11.2009 |
Ehemalige bekannte Positionen von Fredrik Ollila
| Unternehmen | Position | Ende |
|---|---|---|
Vivoxid Oy
 Vivoxid Oy BiotechnologyHealth Technology Vivoxid Oy develops, manufactures and markets biomaterial products and production services within the medical device sector. The company was founded on January 14, 2002 and is headquartered in Helsinki, Finland. | Vertrieb & Marketing | 06.01.2014 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
| NOVARTIS AG | Corporate Officer/Principal | - |
Ausbildung von Fredrik Ollila
| Åbo Akademi University | Doctorate Degree |
| University of Turku | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Vivoxid Oy
Vivoxid Oy BiotechnologyHealth Technology Vivoxid Oy develops, manufactures and markets biomaterial products and production services within the medical device sector. The company was founded on January 14, 2002 and is headquartered in Helsinki, Finland. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
BonAlive Biomaterials Oy
BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland. | Health Technology |
